Equities

Celcuity Inc

CELC:NAQ

Celcuity Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)14.64
  • Today's Change-0.300 / -2.01%
  • Shares traded176.70k
  • 1 Year change+34.44%
  • Beta0.7828
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Celcuity Inc increased its cash reserves by 24.79%, or 6.09m. Cash Flow from Financing totalled 64.91m or -- of revenues. In addition the company used 53.81m for operations while cash used for investing totalled 5.01m.
Cash flow per share-2.68
Price/Cash flow per share--
Book value per share4.77
Tangible book value per share4.77
More ▼

Balance sheet in USDView more

Celcuity Inc has a Debt to Total Capital ratio of 35.25%, a higher figure than the previous year's 32.68%.
Current ratio14.95
Quick ratio--
Total debt/total equity0.5444
Total debt/total capital0.3525
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.